201
Participants
Start Date
September 23, 2021
Primary Completion Date
September 30, 2025
Study Completion Date
December 31, 2026
INBRX-109
Tetravalent DR5 Agonist Antibody
Placebo
Placebo
RECRUITING
Chris O'Brien Lifehouse, Camperdown
RECRUITING
Royal Adelaide Hospital, Adelaide
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
ACTIVE_NOT_RECRUITING
Columbia University, New York
RECRUITING
La Fondazione e l'Istituto di Candiolo, Candiolo
RECRUITING
AP-HM - Hôpital de la Timone, Marseille
RECRUITING
Helios Klinikum Berlin-Buch, Berlin
RECRUITING
University of Pittsburgh Medical Center, Pittsburgh
RECRUITING
Thomas Jefferson University Hospital, Philadelphia
RECRUITING
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
RECRUITING
Johns Hopkins, Baltimore
RECRUITING
Virginia Cancer Specialists, Fairfax
RECRUITING
Duke University, Durham
RECRUITING
Hospital Clinico San Carlos, Madrid
RECRUITING
Hospital Fundación Jiménez Díaz, Madrid
RECRUITING
Mayo Clinic - Jacksonville, Jacksonville
RECRUITING
Institut Bergonie, Bordeaux
RECRUITING
Moffitt Cancer Center, Tampa
RECRUITING
Vanderbilt University Medical Center, Nashville
RECRUITING
IRCCS Istituto Ortopedico Rizzoli di Bologna, Bologna
RECRUITING
Cleveland Clinic, Cleveland
RECRUITING
Hospital Universitari i Politecnic La Fe, Valencia
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
University of Iowa, Iowa City
RECRUITING
Centre Oscar Lambret, Lille
RECRUITING
Nuovo Ospedale di Prato, Prato
RECRUITING
Northwestern University - Robert H. Lurie Comprehensive Cancer Center, Chicago
RECRUITING
Rush Cancer Center, Chicago
RECRUITING
Washington University School of Medicine - St. Louis, St Louis
RECRUITING
Nebraska Methodist Hospital, Omaha
RECRUITING
Universitätsmedizin Mannheim, Mannheim
RECRUITING
Centre Leon Berard, Lyon
RECRUITING
University of Oklahoma - Stephenson Cancer Center, Oklahoma City
RECRUITING
MD Anderson Cancer Center, Houston
RECRUITING
University of Colorado, Denver
RECRUITING
Mayo Clinic Cancer Center, Phoenix
RECRUITING
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone, Palermo
RECRUITING
Precision NextGen Oncology & Research Center, Beverly Hills
RECRUITING
Sarcoma Oncology Center, Santa Monica
RECRUITING
University of California, San Francisco (UCSF), San Francisco
RECRUITING
Gustave Roussy, Villejuif
RECRUITING
Oregon Health & Science University (OHSU) Knight Cancer Institute, Portland
RECRUITING
University of Washington, Seattle
RECRUITING
Yale Cancer Center, New Haven
RECRUITING
Dana Farber Cancer Institute, Boston
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
Norris Cotton Cancer Center, Lebanon
RECRUITING
Princess Alexandra Hospital, Woolloongabba
RECRUITING
Saint Vincent's University Hospital part of Irish Sarcoma Group, Dublin
RECRUITING
Policlinico Universitario Campus Biomedico, Roma
RECRUITING
Groningen UMC, Groningen
RECRUITING
Leiden University Medical Center, Leiden
RECRUITING
Hospital Universitario Vall d'Hebron, Barcelona
RECRUITING
Hospital de la Santa Creu i Sant Pau Barcelona, Barcelona
RECRUITING
University College London Hospital (UCL), London
RECRUITING
Royal Marsden NHS Foundation Trust, London
RECRUITING
The Christie NHS Foundation Trust, Manchester
RECRUITING
Churchill Hospital, Oxford
Lead Sponsor
Inhibrx Biosciences, Inc
INDUSTRY